000			01383 a2200397 4500
005			20250512081722.0
264		0	_c19860421
008			198604s 0 0 eng d
022			_a0004-4172
040			_aNLM _beng _cNLM
100	1		_aDi Francesco, G F
245	0	0	_aHemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs. _h[electronic resource]
260			_bArzneimittel-Forschung _c1986
300			_a84-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCardiac Output _xdrug effects
650	0	4	_aCoronary Circulation _xdrug effects
650	0	4	_aDogs
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHydralazine _xpharmacology
650	0	4	_aMale
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aPulmonary Circulation _xdrug effects
650	0	4	_aPyridazines _xpharmacology
650	0	4	_aRenal Circulation _xdrug effects
650	0	4	_aStroke Volume _xdrug effects
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVasodilator Agents _xpharmacology
700	1		_aBaldoli, E
700	1		_aMarchetti, G
700	1		_aGlässer, A
773	0		_tArzneimittel-Forschung _gvol. 36 _gno. 1 _gp. 84-8
999			_c3960505 _d3960505